朗妮·维克隆

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

   · 2019 · cited 7,623x

2. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

   · 2021 · cited 5,565x

3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

   · 2017 · cited 3,337x

4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR)

   · 2012 · cited 2,888x

5. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

   · 2016 · cited 2,685x

via Crossref · CC0

via Wikidata sitelinks · CC0